Shrinidh Joshi, Yagna P R Jarajapu
Journal: British journal of pharmacology 2020;176(22):4373-4387
PMID: 30367728
BACKGROUND AND PURPOSE
CD34 haematopoietic stem/progenitor cells have revascularization potential and are now being tested for the treatment of ischaemic vascular diseases in clinical trials. We tested the hypothesis that mitochondrial depolarization stimulates the reparative functions of CD34 cells.
EXPERIMENTAL APPROACH
Peripheral blood was obtained from healthy individuals (n = 63), and mononuclear cells (MNCs) were separated. MNCs were enriched for lineage negative cells, followed by isolation of CD34 cells. Vascular repair-relevant functions of CD34 cells, proliferation and migration, were evaluated in the presence and absence of diazoxide. Mitochondrial membrane potential, ROS and NO levels were evaluated by flow cytometry by using JC-1, mitoSOX and DAF-FM respectively.
KEY RESULTS
Diazoxide stimulated the proliferation and migration of CD34 cells that were comparable to the responses induced by stromal-derived factor-1α (SDF) or VEGF. Effects of diazoxide were blocked by either 5-hydroxydecanoate (5HD), a selective mitochondrial ATP-sensitive potassium channel (mitoK ) inhibitor, or by L-NAME. Diazoxide induced mitochondrial depolarization, and NO and cGMP generation that were 5HD-sensitive. The generation of NO and cGMP by diazoxide was blocked by an endothelial NOS (eNOS)-selective inhibitor, NIO, but not by a neuronal (n)NOS-selective inhibitor, N -propyl-L-arginine (NPA). A Ca chelator, BAPTA, Akt inhibitor, triciribine, or PI3K inhibitor, LY294002, inhibited the NO release induced by diazoxide. Phosphorylation of eNOS at Ser and dephosphorylation at Thr were increased. Diazoxide-induced ROS generation and phosphorylation of eNOS at Ser were reduced by NPA.
CONCLUSION AND IMPLICATIONS
Diazoxide stimulates vascular repair-relevant functions of CD34 cells via the mitoK -dependent release of NO and ROS.
LINKED ARTICLES
This article is part of a themed section on Mitochondrial Pharmacology: Featured Mechanisms and Approaches for Therapy Translation. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc.
© 2018 The British Pharmacological Society.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.